( May 21, 2026, 2:02 PM EDT) -- TACOMA, Wash. — After a jury found in favor of Novo Nordisk Inc. (NNI) in a qui tam suit accusing it of violating the federal False Claims Act (FCA) and similar state and city laws, a Washington federal judge granted a motion by a relator and Washington to retax costs against them for witness and transcript fees, agreeing with the relator that though her suit “was not successful, . . . the scrutiny that the case brought was valuable and important.”...